How to buy ADMA Biologics stock (ADMA)

ADMA Biologics is a biotechnology business based in the US. ADMA Biologics shares (ADMA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $17.41 – a decrease of 1.64% over the previous week. ADMA Biologics employs 624 staff and has a trailing 12-month revenue of around $382.8 million.

Our top picks for where to buy ADMA Biologics stock

Buy ADMA Biologics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

ADMA Biologics stock price (NASDAQ: ADMA)

Use our graph to track the performance of ADMA stocks over time.

ADMA Biologics shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$17.41
52-week range	$4.16 - $23.64
50-day moving average more info button	$18.93
200-day moving average more info button	$13.41
Wall St. target price	$24.25
PE ratio more info button	65.5556
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.27

Is it a good time to buy ADMA Biologics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ADMA Biologics price performance over time

Historical closes compared with the close of $17.72 from 2024-12-23

1 week (2024-12-18)	0.11%
1 month (2024-11-25)	-17.47%
3 months (2024-09-25)	-9.08%
6 months (2024-06-25)	60.94%

1 year (2023-12-22)	317.92%
2 years (2022-12-23)	385.48%
3 years (2021-12-23)	1,295.28%
5 years (2019-12-24)	333.25%

Is ADMA Biologics stock undervalued or overvalued?

Valuing ADMA Biologics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ADMA Biologics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

ADMA Biologics's P/E ratio

ADMA Biologics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 66x. In other words, ADMA Biologics shares trade at around 66x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

ADMA Biologics's EBITDA

ADMA Biologics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $125.9 million.

The EBITDA is a measure of a ADMA Biologics's overall financial performance and is widely used to measure a its profitability.

ADMA Biologics financials

Revenue TTM	$382.8 million
Operating margin TTM	33.08%
Gross profit TTM	$35.3 million
Return on assets TTM	19.89%
Return on equity TTM	35.55%
Profit margin	17.8%
Book value	$0.98
Market Capitalization more info button	$4.2 billion

TTM: trailing 12 months

ADMA Biologics share dividends

We're not expecting ADMA Biologics to pay a dividend over the next 12 months.

ADMA Biologics share price volatility

Over the last 12 months, ADMA Biologics's shares have ranged in value from as little as $4.16 up to $23.64. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ADMA Biologics's is 0.645. This would suggest that ADMA Biologics's shares are less volatile than average (for this exchange).

ADMA Biologics overview

ADMA Biologics, Inc. , a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers.

Frequently asked questions

null
What percentage of ADMA Biologics is owned by insiders or institutions?
Currently 2.51% of ADMA Biologics shares are held by insiders and 90.937% by institutions. How many people work for ADMA Biologics?
Latest data suggests 624 work at ADMA Biologics. When does the fiscal year end for ADMA Biologics?
ADMA Biologics's fiscal year ends in December. Where is ADMA Biologics based?
ADMA Biologics's address is: 465 State Route 17, Ramsey, NJ, United States, 07446 What is ADMA Biologics's ISIN number?
ADMA Biologics's international securities identification number is: US0008991046 What is ADMA Biologics's CUSIP number?
ADMA Biologics's Committee on Uniform Securities Identification Procedures number is: 000899104